Resultado final
Description of dominant MPSG in high risk areas (that tend to elect not to participate but which are at high risk), and of MPSG for optimisation in those who tend to participate (M6)
Biomarkers: Validation circulating miRNAValidation of two different computational models of circulating miRNAs to maximize sensitivity for risk prediction and specificity for differential diagnosis
Project Management: informed consent form- The informed consent procedures that will be implemented for the participation of humans will be explained into detail. - providing templates of the informed consent form (per country)
Biomarkers: composite risk predicting panelCombination of miRNAs, inflammatory proteins and cardio-pulmonary damage in a composite risk predicting panel.
recruitment: development tailored recruitmentIdentification of the preferred per country and most effective channels of communication and development of the tailored intervention, with different MPSG profiles, at high risk of developing lung cancer, including qualitative data on the participants’ view of the methods
Protocol: study protocol 4-IN-THE-LUNG-RUNDesign of the study protocol
Data protection: securityA description of the security measures that will be implemented to prevent unauthorised access to personal data or the equipment used for processing
Protocol: Nodule Management Strategydesign of the lung cancer nodule management protocol
Approval: study protocol - registrationi Final version of study protocol as submitted to regulatorsethics committees ii Registration number of clinical study in a WHOor ICMJE approved registry with the possibility to post resultsiii Approvals ethics committees and national competent authority if applicable required for invitationenrolment of first subject in at least one clinical centre
Data protection: privacy - anonymised/ pseudomysed dataexplain why the research data will not be anonymised/ pseudonymised
Publicaciones
Autores:
Kevin Haaf, Carlijn M. Aalst, Harry J. Koning, Rudolf Kaaks, Martin C. Tammemägi
Publicado en:
International Journal of Cancer, Edición 149/2, 2021, Página(s) 250-263, ISSN 0020-7136
Editor:
John Wiley & Sons Inc.
DOI:
10.1002/ijc.33578
Autores:
Carlijn M. van der Aalst, Kevin ten Haaf, Harry J. de Koning
Publicado en:
Translational Lung Cancer Research, Edición 10/2, 2021, Página(s) 1050-1063, ISSN 2218-6751
Editor:
AME Publishing Company
DOI:
10.21037/tlcr-20-985
Autores:
M. Vonder, C. van der Aalst, J. Hubert, D. Moldovanu, A. Schmitz, J.W.C. Gratama, M. Silva, H. de Koning, M. Oudkerk
Publicado en:
Journal of Thoracic Oncology, Edición Volume 18, Edición 11, Supplement, 2023, 2023, Página(s) Pages S218-S219, ISSN 1556-0864
Editor:
Lippincott Williams & Wilkins Ltd.
DOI:
10.1016/j.jtho.2023.09.355
Autores:
Koen de Nijs, Kevin ten Haaf, Carlijn van der Aalst, and Harry J. de Koning
Publicado en:
eClinical Medicine, Edición 2024; 102570, 2024, Página(s) 102570, ISSN 2589-5370
Editor:
Elsevier BV
DOI:
10.1016/j.eclinm.2024.102570
Autores:
M. Vonder, C. van der Aalst, D. Moldovanu, J. Hubert, A. Schmitz, J. Gratama, M. Silva, H. de Koning, M. Oudkerk
Publicado en:
Journal of Cardiovascular Computed Tomography, Edición Volume 17, Edición 4, Supplement, 2023, Página(s) S46, ISSN 1934-5925
Editor:
Elsevier BV
DOI:
10.1016/j.jcct.2023.05.116
Autores:
Dana Moldovanu, Harry J. de Koning, Carlijn M. van der Aalst
Publicado en:
Translational Lung Cancer Research, Edición 10/2, 2021, Página(s) 1099-1109, ISSN 2218-6751
Editor:
AME Publishing Company
DOI:
10.21037/tlcr-20-899
Autores:
C. van der Aalst, M. Vonder, J. Hubert, D. Moldovanu, A. Schmitz, S. Delorme, R. Kaaks, K. ten Haaf , M. Oudkerk, H. de Koning
Publicado en:
Journal of Thoracic Oncology, Edición Volume 18, Edición 11, Supplement, November 2023, 2023, Página(s) Page S217, ISSN 1556-1380
Editor:
Elsevier
DOI:
10.1016/j.jtho.2023.09.352
Autores:
M. Vonder, C. van der Aalst, J. Hubert, D. Moldovanu, A. Schmitz, S. Delorme, J.W. Gratama, M. Silva, H. de Koning, M. Oudkerk
Publicado en:
Journal of Thoracic Oncology, Edición Volume 18, Edición 11, Supplement, November 2023, 2023, Página(s) Page S172, ISSN 1556-1380
Editor:
Elsevier
DOI:
10.1016/j.jtho.2023.09.256
Buscando datos de OpenAIRE...
Se ha producido un error en la búsqueda de datos de OpenAIRE
No hay resultados disponibles